MPLT · MapLight Therapeutics, Inc.
Market Cap
$581.58M
Shares
46.38M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-$161.15M
-107.7%
FY2025
Diluted EPS
-$18.56
+82.4%
FY2025
Operating Cash Flow
-$138.14M
-75.3%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 |
|---|---|---|---|
| $198.84M | $138.35M | $68.52M | |
| $44.09M | $30.73M | $14.42M | |
| $242.93M | $169.08M | $82.95M | |
| -$242.93M | -$169.08M | -$82.95M | |
| $8.84M | $5.52M | $4.5M | |
| $9.78M | $7.93M | $5.37M | |
| -$229.83M | -$161.15M | -$77.58M | |
| -$230.82M | -$161.54M | -$77.42M | |
| USD/shares | $47.22 | -$18.56 | -$105.38 |
| USD/shares | $47.22 | -$18.56 | -$105.38 |
| shares | — | 8.68M | 736.18K |
| shares | — | 8.68M | 736.18K |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 4.98×
EV/EBIT
—
Peer median 11.11×
P/E (TTM)
—
Peer median 12.89×
Peer medians compare against the 305 similar-size Biotechnology companies (of 508 listed).
Key facts
CIK
1770069
CUSIP
56565P103
13F (30d)
99 filings
97 filers
Visit website
Investor relations